BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24349193)

  • 1. Simultaneous in vitro characterisation of DNA deaminase function and associated DNA repair pathways.
    Franchini DM; Incorvaia E; Rangam G; Coker HA; Petersen-Mahrt SK
    PLoS One; 2013; 8(12):e82097. PubMed ID: 24349193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive repair pathways in immunoglobulin gene hypermutation.
    Reynaud CA; Delbos F; Faili A; Guéranger Q; Aoufouchi S; Weill JC
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):613-9. PubMed ID: 19010770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin Class Switch Recombination Is Initiated by Rare Cytosine Deamination Events at Switch Regions.
    Kim A; Han L; Yu K
    Mol Cell Biol; 2020 Jul; 40(16):. PubMed ID: 32513818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BRCT domain of PARP-1 is required for immunoglobulin gene conversion.
    Paddock MN; Buelow BD; Takeda S; Scharenberg AM
    PLoS Biol; 2010 Jul; 8(7):e1000428. PubMed ID: 20652015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyuridine is generated preferentially in the nontranscribed strand of DNA from cells expressing activation-induced cytidine deaminase.
    Martomo SA; Fu D; Yang WW; Joshi NS; Gearhart PJ
    J Immunol; 2005 Jun; 174(12):7787-91. PubMed ID: 15944282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
    Gu X; Booth CJ; Liu Z; Strout MP
    Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.
    Diaz M; Lawrence C
    Trends Immunol; 2005 Apr; 26(4):215-20. PubMed ID: 15797512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination.
    Besmer E; Market E; Papavasiliou FN
    Mol Cell Biol; 2006 Jun; 26(11):4378-85. PubMed ID: 16705187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
    Pilzecker B; Jacobs H
    Front Immunol; 2019; 10():438. PubMed ID: 30915081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AID-induced DNA damage response in chromatin.
    Daniel JA; Nussenzweig A
    Mol Cell; 2013 May; 50(3):309-21. PubMed ID: 23664375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined nuclear and nucleolar localization motif in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching.
    Hu Y; Ericsson I; Torseth K; Methot SP; Sundheim O; Liabakk NB; Slupphaug G; Di Noia JM; Krokan HE; Kavli B
    J Mol Biol; 2013 Jan; 425(2):424-43. PubMed ID: 23183374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strikingly different properties of uracil-DNA glycosylases UNG2 and SMUG1 may explain divergent roles in processing of genomic uracil.
    Doseth B; Ekre C; Slupphaug G; Krokan HE; Kavli B
    DNA Repair (Amst); 2012 Jun; 11(6):587-93. PubMed ID: 22483865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase.
    Nabel CS; Lee JW; Wang LC; Kohli RM
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14225-30. PubMed ID: 23942124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What role for AID: mutator, or assembler of the immunoglobulin mutasome?
    Reynaud CA; Aoufouchi S; Faili A; Weill JC
    Nat Immunol; 2003 Jul; 4(7):631-8. PubMed ID: 12830138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class-switch recombination: after the dawn of AID.
    Kenter AL
    Curr Opin Immunol; 2003 Apr; 15(2):190-8. PubMed ID: 12633669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REV7 is required for processing AID initiated DNA lesions in activated B cells.
    Yang D; Sun Y; Chen J; Zhang Y; Fan S; Huang M; Xie X; Cai Y; Shang Y; Gui T; Sun L; Hu J; Dong J; Yeap LS; Wang X; Xiao W; Meng FL
    Nat Commun; 2020 Jun; 11(1):2812. PubMed ID: 32499490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA/RNA hybrid substrates modulate the catalytic activity of purified AID.
    Abdouni HS; King JJ; Ghorbani A; Fifield H; Berghuis L; Larijani M
    Mol Immunol; 2018 Jan; 93():94-106. PubMed ID: 29161581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinogenic phenotype of human activation-induced cytosine deaminase.
    Poltoratsky VP; Wilson SH; Kunkel TA; Pavlov YI
    J Immunol; 2004 Apr; 172(7):4308-13. PubMed ID: 15034045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing AID and DNA repair during somatic hypermutation.
    Liu M; Schatz DG
    Trends Immunol; 2009 Apr; 30(4):173-81. PubMed ID: 19303358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced cytidine deaminase induces DNA break repair events more frequently in the Ig switch region than other sites in the mammalian genome.
    Lee SA; Parsa JY; Martin A; Baker MD
    Eur J Immunol; 2007 Dec; 37(12):3529-39. PubMed ID: 18034427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.